AIベースの臨床試験ソリューションプロバイダーの世界市場レポート 2025年

AIベースの臨床試験ソリューションプロバイダー市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR23.0%で69億6,000万米ドルに成長します。予測期間の成長は、リアルワールドエビデンス（REW）との統合、自然言語処理（NPL）の進歩、臨床試験の分散化、治療領域の拡大、予測分析の強化などに起因すると考えられます。予測期間における主な動向としては、バイオテクノロジー企業や製薬企業との連携、患者中心のアプローチ、試験デザインのための予測分析、リアルワールドエビデンスとの統合、データセキュリティのためのブロックチェーンなどが挙げられます。

AI技術の採用拡大が、今後のAIベースの臨床試験ソリューションプロバイダー市場の拡大を牽引すると予測されます。AI（人工知能）は、通常人間の知能を必要とするタスクを実行できるコンピュータシステムやソフトウェアの開発を含みます。臨床試験ソリューション・プロバイダーは、臨床試験プロセスのさまざまな段階を通じて効率性、正確性、革新性を高め、患者の転帰の改善や医学研究の進歩につなげるため、AI技術を活用するケースが増えています。例えば、2022年5月、米国のテクノロジー企業であるインターナショナル・ビジネス・マシーンズ・コーポレーション（IBM）は、AIの採用率が前年比35％増となり、世界的に大幅に上昇したと報告しました。さらに、約35％の組織が自社でAIを導入していると報告し、42％が導入を検討しており、3分の2（66％）が持続可能性の目標を達成するためにAIを現在導入しているか、活用する予定であるとしています。その結果、AI技術の採用が増加しており、AIベースの臨床試験ソリューションプロバイダー市場の成長を促進しています。

AIベースの臨床試験ソリューションプロバイダー市場の主要企業は、臨床開発を迅速化し、市場での地位を強化するために、Saama AI主導型データプラットフォームなどの革新的な技術ソリューションを積極的に開発しています。AI主導型データプラットフォームは、人工知能（AI）と機械学習（ML）を活用して、さまざまなデータ管理・分析プロセスを自動化・強化します。例えば、2023年6月、米国のソフトウェア会社であるSaama Technologies, Inc.は、Saama AI-driven data platformを発表しました。このプラットフォームは、データを一元化・標準化することで臨床試験プロセスを最適化し、試験業務、財務、患者データに関するリアルタイムな洞察を提供します。AIと高度な分析を採用することで、このプラットフォームはタスクを自動化し、生産性を高め、患者の行動に関する深い洞察を提供します。Saamaは、データハブ、オペレーションインサイト、患者インサイト、S2S、SDQなどのSaaSソリューションを通じて、AIベースの臨床試験ソリューションプロバイダーが効率性、正確性、有効性を最大化し、手作業やリソース集約的な作業を削減して臨床試験を合理化できるよう支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界AIベースの臨床試験ソリューションプロバイダーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のAIベースの臨床試験ソリューションプロバイダー市場：成長率分析
• 世界のAIベースの臨床試験ソリューションプロバイダー市場の実績：規模と成長, 2019-2024
• 世界のAIベースの臨床試験ソリューションプロバイダー市場の予測：規模と成長, 2024-2029, 2034F
• 世界AIベースの臨床試験ソリューションプロバイダー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のAIベースの臨床試験ソリューションプロバイダー市場臨床試験の段階別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェーズI
• フェーズII
• フェーズIII
• 世界のAIベースの臨床試験ソリューションプロバイダー市場治療用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 心血管疾患
• 神経疾患または症状
• 代謝性疾患
• 感染症
• その他の治療用途
• 世界のAIベースの臨床試験ソリューションプロバイダー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• 学術界
• その他のエンドユーザー
• 世界のAIベースの臨床試験ソリューションプロバイダー市場、フェーズIのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 安全性と投与量に関する研究
• 初期の薬物動態研究
• 世界のAIベースの臨床試験ソリューションプロバイダー市場、タイプ別フェーズ IIのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 有効性研究
• 用量反応研究
• 世界のAIベースの臨床試験ソリューションプロバイダー市場、タイプ別フェーズIIIのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 確認研究
• 比較効果調査

第7章 地域別・国別分析

• 世界のAIベースの臨床試験ソリューションプロバイダー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のAIベースの臨床試験ソリューションプロバイダー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• AIベースの臨床試験ソリューションプロバイダー市場：競合情勢
• AIベースの臨床試験ソリューションプロバイダー市場：企業プロファイル
  • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • BenevolentAI SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Charles River Laboratories
• Flatiron Health
• Saama Technologies Inc.
• CytoReason
• Median Technologies SAS
• Concentro Health AI.
• AiCure, LLC
• DEEP LENS AI Inc.
• GNS Healthcare, Inc.
• Ardigen
• Koneksa Health Inc.
• Unlearn.AI Inc.
• PathAI Inc.
• Deep 6 AI Inc.
• Intelligencia Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• AIベースの臨床試験ソリューションプロバイダー市場2029：新たな機会を提供する国
• AIベースの臨床試験ソリューションプロバイダー市場2029：新たな機会を提供するセグメント
• AIベースの臨床試験ソリューションプロバイダー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

AI-based clinical trial solution providers are entities that offer technological solutions utilizing artificial intelligence (AI) for different facets of the clinical trial process in the healthcare and pharmaceutical sectors. These solutions aim to improve the efficiency, accuracy, and overall effectiveness of clinical trials, ranging from study design and patient recruitment to data analysis and regulatory compliance.

The main types of clinical trial phases addressed by AI-based clinical trial solution providers include phase I, phase II, and phase III. Phase I represents the initial stage of clinical trials conducted during the development of a new medical intervention, such as a drug, vaccine, or medical device. These solutions cater to various therapeutic applications, including oncology, cardiovascular diseases, neurological conditions, metabolic disorders, infectious diseases, and others. They are utilized by end-users such as pharmaceutical companies, academia, and other stakeholders involved in clinical research.

The AI-based clinical trial solution providers market research report is one of a series of new reports from The Business Research Company that provides AI-based clinical trial solution providers market statistics, including AI-based clinical trial solution providers industry global market size, regional shares, competitors with a AI-based clinical trial solution providers market share, detailed AI-based clinical trial solution providers market segments, market trends and opportunities, and any further data you may need to thrive in the AI-based clinical trial solution providers industry. This AI-based clinical trial solution providers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI-based clinical trial solution providers market size has grown exponentially in recent years. It will grow from $2.47 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increasing complexity in clinical trials, growing volume of clinical trial data, regulatory compliance challenges, drug discovery and development demands, personalized medicine trends.

The AI-based clinical trial solution providers market size is expected to see exponential growth in the next few years. It will grow to $6.96 billion in 2029 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to integration with real-world evidence (REW), advancements in natural language processing (NPL), decentralized clinical trials adoption, expansion of therapeutic areas, enhanced predictive analytics. Major trends in the forecast period include collaboration with biotech and pharma companies, patient-centric approaches, predictive analytics for trial design, real-world evidence integration, blockchain for data security.

The growing adoption of AI technology is anticipated to drive the expansion of the market for AI-based clinical trial solution providers in the future. AI, or artificial intelligence, involves the development of computer systems or software capable of performing tasks typically requiring human intelligence. Clinical trial solution providers are increasingly leveraging AI technology to enhance efficiency, accuracy, and innovation throughout various stages of the clinical trial process, leading to improved patient outcomes and advancements in medical research. For example, in May 2022, The International Business Machines Corporation (IBM), a US-based technology corporation, reported a significant global increase in the adoption rate of AI, with a 35% rise compared to the previous year. Moreover, around 35% of organizations reported adopting AI in their company, while 42% are considering its adoption, and two-thirds (66%) are either currently implementing or planning to utilize AI to achieve their sustainability goals. Consequently, the rising adoption of AI technology is fueling the growth of the AI-based clinical trial solution provider market.

Leading companies in the AI-based clinical trial solution providers market are actively developing innovative technological solutions, such as the Saama AI-driven data platform, to expedite clinical development and reinforce their market position. An AI-driven data platform utilizes artificial intelligence (AI) and machine learning (ML) to automate and enhance various data management and analysis processes. For instance, in June 2023, Saama Technologies, Inc., a US-based software company, unveiled the Saama AI-driven data platform. This platform optimizes clinical trial processes by centralizing and standardizing data, providing real-time insights into trial operations, financials, and patient data. By employing AI and advanced analytics, the platform automates tasks, boosts productivity, and delivers profound insights into patient behaviors. Through SaaS solutions such as data hubs, operational insights, patient insights, S2S, and SDQ, Saama empowers AI-based clinical trial solution providers to maximize efficiency, accuracy, and effectiveness while reducing manual, resource-intensive activities to streamline clinical trials.

In September 2023, Florence Healthcare, a US-based healthcare company, acquired VersaTrial Inc. for an undisclosed sum. This acquisition brings together two pioneering entities in the eClinical space, combining their complementary strengths to deliver a more robust solution for research sites, CROs, and sponsors. VersaTrial Inc. is a US-based provider of AI-based clinical trial solutions.

Major companies operating in the AI-based clinical trial solution providers market report are International Business Machines Corporation, AstraZeneca, Takeda Pharmaceutical Company Limited, IQVIA Holdings Inc., BenevolentAI SA, Charles River Laboratories, Flatiron Health, Saama Technologies Inc., CytoReason, Median Technologies SAS, Concentro Health AI., AiCure, LLC, DEEP LENS AI Inc., GNS Healthcare, Inc., Ardigen, Koneksa Health Inc., Unlearn.AI Inc., PathAI Inc., Deep 6 AI Inc., Intelligencia Inc., Exscientia, Prometheus Biosciences, Inc., Renalytix AI PLC, BioAge Labs Inc., Mendel Health Inc

North America was the largest region in the AI-based clinical trial solution providers market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai-based clinical trial solution providers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI-based clinical trial solution provider market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI-based clinical trial solution provider market consists of revenues earned by entities by providing services such as data analysis, patient recruitment and retention, drug trial process optimization, and predictive analytics for clinical outcomes. The AI-based clinical trial solution providers market also includes sales of mobile devices, medical devices and servers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI-Based Clinical Trial Solution Providers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai-based clinical trial solution providers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai-based clinical trial solution providers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai-based clinical trial solution providers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Clinical Trial Phase: Phase-I; Phase-Ii; Phase-Iii
• 2) By Therapeutic Application: Oncology; Cardiovascular Diseases; Neurological Diseases Or Conditions Metabolic Diseases; Infectious Diseases; Other Therapeutic Applications
• 3) By End-User: Pharmaceutical Companies; Academia; Other End-Users
• Subsegments:
• 1) By Phase-I: Safety And Dosage Studies; Early Pharmacokinetics Studies
• 2) By Phase-Ii: Efficacy Studies; Dose-Response Studies
• 3) By Phase-Iii: Confirmatory Studies; Comparative Effectiveness Research
• Companies Mentioned: International Business Machines Corporation; AstraZeneca; Takeda Pharmaceutical Company Limited; IQVIA Holdings Inc.; BenevolentAI SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI-Based Clinical Trial Solution Providers Market Characteristics

3. AI-Based Clinical Trial Solution Providers Market Trends And Strategies

4. AI-Based Clinical Trial Solution Providers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global AI-Based Clinical Trial Solution Providers Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI-Based Clinical Trial Solution Providers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI-Based Clinical Trial Solution Providers Market Growth Rate Analysis
• 5.4. Global AI-Based Clinical Trial Solution Providers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI-Based Clinical Trial Solution Providers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI-Based Clinical Trial Solution Providers Total Addressable Market (TAM)

6. AI-Based Clinical Trial Solution Providers Market Segmentation

• 6.1. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase-I
• Phase-II
• Phase-III
• 6.2. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiovascular Diseases
• Neurological Diseases Or Conditions
• Metabolic Diseases
• Infectious Diseases
• Other Therapeutic Applications
• 6.3. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Academia
• Other End-Users
• 6.4. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Safety And Dosage Studies
• Early Pharmacokinetics Studies
• 6.5. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-Ii, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Efficacy Studies
• Dose-Response Studies
• 6.6. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-Iii, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Confirmatory Studies
• Comparative Effectiveness Research

7. AI-Based Clinical Trial Solution Providers Market Regional And Country Analysis

• 7.1. Global AI-Based Clinical Trial Solution Providers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI-Based Clinical Trial Solution Providers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI-Based Clinical Trial Solution Providers Market

• 8.1. Asia-Pacific AI-Based Clinical Trial Solution Providers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI-Based Clinical Trial Solution Providers Market

• 9.1. China AI-Based Clinical Trial Solution Providers Market Overview
• 9.2. China AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI-Based Clinical Trial Solution Providers Market

• 10.1. India AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI-Based Clinical Trial Solution Providers Market

• 11.1. Japan AI-Based Clinical Trial Solution Providers Market Overview
• 11.2. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI-Based Clinical Trial Solution Providers Market

• 12.1. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI-Based Clinical Trial Solution Providers Market

• 13.1. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI-Based Clinical Trial Solution Providers Market

• 14.1. South Korea AI-Based Clinical Trial Solution Providers Market Overview
• 14.2. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI-Based Clinical Trial Solution Providers Market

• 15.1. Western Europe AI-Based Clinical Trial Solution Providers Market Overview
• 15.2. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI-Based Clinical Trial Solution Providers Market

• 16.1. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI-Based Clinical Trial Solution Providers Market

• 17.1. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI-Based Clinical Trial Solution Providers Market

• 18.1. France AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI-Based Clinical Trial Solution Providers Market

• 19.1. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI-Based Clinical Trial Solution Providers Market

• 20.1. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI-Based Clinical Trial Solution Providers Market

• 21.1. Eastern Europe AI-Based Clinical Trial Solution Providers Market Overview
• 21.2. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI-Based Clinical Trial Solution Providers Market

• 22.1. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI-Based Clinical Trial Solution Providers Market

• 23.1. North America AI-Based Clinical Trial Solution Providers Market Overview
• 23.2. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI-Based Clinical Trial Solution Providers Market

• 24.1. USA AI-Based Clinical Trial Solution Providers Market Overview
• 24.2. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI-Based Clinical Trial Solution Providers Market

• 25.1. Canada AI-Based Clinical Trial Solution Providers Market Overview
• 25.2. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI-Based Clinical Trial Solution Providers Market

• 26.1. South America AI-Based Clinical Trial Solution Providers Market Overview
• 26.2. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI-Based Clinical Trial Solution Providers Market

• 27.1. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI-Based Clinical Trial Solution Providers Market

• 28.1. Middle East AI-Based Clinical Trial Solution Providers Market Overview
• 28.2. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI-Based Clinical Trial Solution Providers Market

• 29.1. Africa AI-Based Clinical Trial Solution Providers Market Overview
• 29.2. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI-Based Clinical Trial Solution Providers Market Competitive Landscape And Company Profiles

• 30.1. AI-Based Clinical Trial Solution Providers Market Competitive Landscape
• 30.2. AI-Based Clinical Trial Solution Providers Market Company Profiles
  • 30.2.1. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BenevolentAI SA Overview, Products and Services, Strategy and Financial Analysis

31. AI-Based Clinical Trial Solution Providers Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories
• 31.2. Flatiron Health
• 31.3. Saama Technologies Inc.
• 31.4. CytoReason
• 31.5. Median Technologies SAS
• 31.6. Concentro Health AI.
• 31.7. AiCure, LLC
• 31.8. DEEP LENS AI Inc.
• 31.9. GNS Healthcare, Inc.
• 31.10. Ardigen
• 31.11. Koneksa Health Inc.
• 31.12. Unlearn.AI Inc.
• 31.13. PathAI Inc.
• 31.14. Deep 6 AI Inc.
• 31.15. Intelligencia Inc.

32. Global AI-Based Clinical Trial Solution Providers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI-Based Clinical Trial Solution Providers Market

34. Recent Developments In The AI-Based Clinical Trial Solution Providers Market

35. AI-Based Clinical Trial Solution Providers Market High Potential Countries, Segments and Strategies

• 35.1 AI-Based Clinical Trial Solution Providers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI-Based Clinical Trial Solution Providers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI-Based Clinical Trial Solution Providers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer